Glenmark Pharmaceuticals climbs to
#2 position for the respiratory segment
in the Indian Pharmaceutical Market*.
*IQVIA SSA MAT March 2023
It is a testament of our positive and inclusive workplace culture where the entire team feels valued, respected, and empowered to do their best at work. We will continue to strive for excellence in all that we do and to support our employees in achieving their full potential.
At Glenmark, we believe in enriching lives and making a difference to patients all over the world. We constantly strive to find new ways that pave the way for a healthier tomorrow.
We are creating centers of excellence in dermatology, oncology and respiratory therapy. The effort is to develop advance therapies to enrich the lives of patients worldwide.
A HEALTHIER WORLD.
With 14 manufacturing facilities in four countries and 4 R&D centres spanning across GPL and GLS, we work relentlessly towards improving the quality of life of patients across the globe.
Employees based out of 50+ offices all over the world working towards one mission - Enriching lives globally.
INVESTOR CORNER
LATEST ANNOUNCEMENTS